Genmab Collaborates With Lilly On DuoBody Platform - - BioPharm International

ADVERTISEMENT

Genmab Collaborates With Lilly On DuoBody Platform



Genmab A/S has entered into a research collaboration with Eli Lilly to use and evaluate Genmab's DuoBody technology platform for the creation of bispecific antibodies. Under the collaboration, Lilly will initially evaluate the DuoBody technology platform in
house. The financial terms of the agreement have not been disclosed. This agreement will not have a material impact on Genmab's financial results and cash position.

Source: Genmab A/S

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Novartis Personalized Cell Therapy Receives FDA Breakthrough Therapy Designation
July 9, 2014
FDA Urged to Preserve Biosimilar Naming Conventions
July 2, 2014
Merck Collaborates with Bionomics on Alzheimer's Treatments
July 1, 2014
EMA Revises Guidance on Advanced Therapies
July 1, 2014
EMD Serono and Mersana to Develop Next-Generation Antibody-Drug Conjugates
July 1, 2014
Author Guidelines

Click here